Suppr超能文献

第二代和第三代口服避孕药对超重及肥胖女性脂质和碳水化合物代谢的影响:一项随机三盲对照试验

Effects of Second and Third Generation Oral Contraceptives on Lipid and Carbohydrate Metabolism in Overweight and Obese Women: A Randomized Triple-Blind Controlled Trial.

作者信息

Shahnazi Mahnaz, Farshbaf-Khalili Azizeh, Pourzeinali-Beilankouh Samira, Sadrimehr Farnaz

机构信息

Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, IR Iran.

Department of Midwifery, Nursing and Midwifery Faculty, Tabriz Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, IR Iran.

出版信息

Iran Red Crescent Med J. 2016 Jun 19;18(9):e36982. doi: 10.5812/ircmj.36982. eCollection 2016 Sep.

Abstract

BACKGROUND

Combined oral contraceptives (COCs) have not been shown to have major effects on lipid and carbohydrate metabolism in normal-weight women. However, we have limited information about the effects on women at high risk for cardiovascular disease and diabetes due to being overweight and obese.

OBJECTIVES

To evaluate the effects of second and third generation contraceptive pills on lipid and carbohydrate metabolism in overweight and obese women.

PATIENTS AND METHODS

This triple-blind controlled trial was performed on 137 healthy women aged 18 - 40 years with a body mass index of 25-34.9 (kg/m) who were referred to health centers in Tabriz, Iran from 2014 to 2015. The women were randomly divided into groups who were to take 30 mcg ethinyl estradiol/150 mcg levonorgestrel (EE/LGN) (n = 69) or 30 mcg ethinyl estradiol/150 mcg desogestrel (EE/DSG) (n = 68) with an allocation ratio of 1: 1 for three cycles. As primary outcomes, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and fasting plasma glucose (FPG) were assessed; total cholesterol (TC), triglycerides (TG), and 2-hour plasma glucose in the 75-g oral glucose tolerance test (2-hour 75-g OGTT) were assessed as secondary outcomes.

RESULTS

The differences in lipid and carbohydrate parameters were not significant between the two groups, except for HDL-C (Adjusted MD (CI95%) = 7.00 (2.98 to 11.02)). HDL-C decreased with EE/LGN (P = 0.016) and increased with EE/DSG (P = 0.004). LDL-C and TC increased in both groups, whereas TG increased only with EE/DSG (P < 0.05). Compared with the baseline, FPG levels did not differ significantly in both groups, but EE/DSG increased 2-hour 75-g OGTT (P = 0.010).

CONCLUSIONS

We observed no significant differences between the two groups in lipid and carbohydrate metabolism, except for HDL-C. Considering the importance of overweight and obese women's health, studies with longer follow-up periods are recommended in this respect.

摘要

背景

复方口服避孕药(COCs)对体重正常的女性的脂质和碳水化合物代谢未显示出重大影响。然而,对于因超重和肥胖而具有心血管疾病和糖尿病高风险的女性,其影响的相关信息有限。

目的

评估第二代和第三代避孕药对超重和肥胖女性脂质和碳水化合物代谢的影响。

患者和方法

这项三盲对照试验于2014年至2015年在伊朗大不里士的健康中心对137名年龄在18 - 40岁、体重指数为25 - 34.9(kg/m)的健康女性进行。这些女性被随机分为两组,一组服用30微克炔雌醇/150微克左炔诺孕酮(EE/LGN)(n = 69),另一组服用30微克炔雌醇/150微克去氧孕烯(EE/DSG)(n = 68),分配比例为1:1,为期三个周期。作为主要结局指标,评估高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和空腹血糖(FPG);作为次要结局指标,评估总胆固醇(TC)、甘油三酯(TG)以及75克口服葡萄糖耐量试验中的2小时血糖(2小时75克OGTT)。

结果

两组之间的脂质和碳水化合物参数差异不显著,但HDL-C除外(调整后的MD(CI95%)= 7.00(2.98至11.02))。HDL-C在服用EE/LGN时降低(P = 0.016),在服用EE/DSG时升高(P = 0.004)。两组的LDL-C和TC均升高,而TG仅在服用EE/DSG时升高(P < 0.05)。与基线相比,两组的FPG水平无显著差异,但EE/DSG使2小时75克OGTT升高(P = 0.010)。

结论

除HDL-C外,我们观察到两组在脂质和碳水化合物代谢方面无显著差异。考虑到超重和肥胖女性健康的重要性,建议在这方面进行更长随访期的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e9/5253509/89a602ce064d/ircmj-18-09-36982-i001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验